Gilead Sciences, Inc. (NASDAQ:GILD)

CAPS Rating: 4 out of 5

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Recs

1
Player Avatar manirg (75.88) Submitted: 6/14/2013 12:48:02 PM : Outperform Start Price: $52.38 GILD Score: +81.53

leader in AIDS treatment

Featured Broker Partners


Advertisement